Key result
Serotonin was a potent pulmonary vasoconstrictor in an experimental preparation, and its effects were potently blocked by promethazine, LSD-25, and its 2-brom derivative.
Serotonin acts as a potent pulmonary vasoconstrictor in an experimental model, an effect that can be blocked by promethazine and LSD derivatives.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for serotonin blockade in pulmonary vascular models; leaves open clinical translation.
Serotonin was the most potent pulmonary vasoconstrictor studied in an experimental preparation in which drugs injected into the pulmonary artery are temporarily excluded from the systemic circulation. Alterations in bronchomotor tone did not approach those produced by acetylcholine. Simultaneous systemic vascular or cardiac reflexes were not noted. Promethazine, LSD-25 and its 2-brom derivative were potent blockers of serotonin effects in the pulmonary circulation.
No takes yet. Share an insight, caveat, or question.
Rose et al. (1958) studied this question. Serotonin and serotonin antagonists (Promethazine, LSD-25, 2-brom derivative) was evaluated on Pulmonary vasoconstriction and bronchomotor tone. Serotonin was a potent pulmonary vasoconstrictor in an experimental preparation, and its effects were potently blocked by promethazine, LSD-25, and its 2-brom derivative.
Synapse has enriched 10 related papers. Consider them for comparative context: